Real-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center Study
Journal of Drugs in Dermatology · 01.08.2024 · 23 (8) · 632-639
DOI: 10.36849/jdd.7486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.07.2024. Verfasst von Luigi Gargiulo und 9 weiteren Autor:innen. Hauptthemen laut MEDLINE: Psoriasis, Antibodies, Monoclonal, Humanized, Severity of Illness Index. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Gargiulo, L., Ibba, L., Cortese, A., Toso, F., Vignoli, C. A., Fiorillo, G., Piscazzi, F., Valenti, M., Costanzo, A., & Narcisi, A. (2024). Real-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center Study. Journal of Drugs in Dermatology, 23(8), 632-639. https://doi.org/10.36849/jdd.7486
Vancouver
Gargiulo L, Ibba L, Cortese A, Toso F, Vignoli CA, Fiorillo G, et al. Real-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center Study. Journal of Drugs in Dermatology. 2024;23(8):632-639. doi:10.36849/jdd.7486
BibTeX
@article{Gargiulo2024,
author = {Gargiulo, Luigi and Ibba, Luciano and Cortese, Andrea and Toso, Francesco and Vignoli, Carlo A and Fiorillo, Giovanni and Piscazzi, Francesco and Valenti, Mario and Costanzo, Antonio and Narcisi, Alessandra},
title = {Real-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center Study},
journal = {Journal of Drugs in Dermatology},
year = {2024},
volume = {23},
number = {8},
pages = {632--639},
doi = {10.36849/jdd.7486}
}
EUVIMED